Project Grant R24AI191867
Award Date 8/11/25
Completion Date 7/31/30
Dollars Obligated $401K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
- This $859,083 Project Grant, awarded on August 21, 2025 by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), supports the Southeastern HIV Implementation Science Hub led by Vanderbilt University Medical Center (VUMC). The Hub aims to enhance the sustained implementation of evidence-based HIV diagnosis, treatment, and prevention services among academic, community, and clinical partners in the southeastern U.S. The project will...
- This federal Project Grant award of $738,030 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the University of Alabama at Birmingham (UAB) in establishing the UAB Regional Consultation Hub for Precision HIV Implementation Science. The Hub serves as a resource for investigators and community partners in the U.S. Deep South region, which is heavily burdened by HIV. Over the 5-year award...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a 5-year, $1,546,730 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to support the continuation and expansion of the Johns Hopkins HIV Implementation Science Hub (Hopkins Hub). The key objectives of this award are to: 1) enhance the technical rigor of implementation science research and build capacity among investigators focused on ending...
- The University of California, San Diego (UCSD) received a $702,788 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), to establish the San Diego Implementation Science Hub (SD IS Hub). The SD IS Hub applies implementation science principles to support the objectives of the NIH Ending the HIV Epidemic (EHE) initiative by providing technical consultation and support to...
- This $658,019 Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The purpose of the award is to establish a Rigorous, Rapid, and Relevant Evidence Adaptation and Implementation (R3EDI) Consultation Hub to support the Ending the HIV Epidemic (EHE) initiative. The R3EDI Hub will provide technical assistance, training resources, and consultation support to EHE...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $721,721 to the University of California, Los Angeles (UCLA) to establish the UCLA RAPID, RIGOROUS, RELEVANT IMPLEMENTATION SCIENCE HUB. This five-year grant, running from August 1, 2025 to July 31, 2030, will leverage implementation science to enhance the translation of HIV research into routine clinical practice and improve population health outcomes. Key objectives include providing technical...
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $1,505,785 Project Grant to Northwestern University to support the HIV Implementation Science Coordination Initiative (ISCI). The grant, awarded on Sep 3, 2025, with a completion date of Aug 31, 2030, aims to: 1) Integrate implementation and effectiveness data across NIAID's Ending the HIV Epidemic (EHE)-funded projects to create...
- The University of Washington (UW) was awarded a $1,246,486 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) on May 13, 2025. The purpose of this grant is to establish the Research Alliance in Implementation Science to End HIV (RAISE) Regional Consultative Hub, which will support Ending the HIV Epidemic (EHE) implementation science efforts in priority jurisdictions. Through...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855) provides $812,427 to the University of California, San Diego (UCSD) to develop an interactive online data dashboard. The dashboard will integrate de-identified and aggregated HIV sequence data with publicly available Ending the HIV Epidemic (EHE) prevention and treatment data to identify regions with heightened HIV...
- This $624,902 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to investigate the impact of the HIV accessory protein Vpr on epigenetic remodeling and viral persistence in myeloid cells. The 5-year project, starting on Apr 23, 2025, will focus on characterizing how Vpr induces epigenetic changes to facilitate sustained HIV transcription and latency reactivation, as well as...